Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Kevin Bielamowicz

Concepts (141)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medulloblastoma
4
2022
17
1.170
Why?
T-Lymphocytes
8
2025
325
1.160
Why?
Brain Neoplasms
10
2024
281
1.130
Why?
Glioblastoma
6
2018
94
1.100
Why?
Histiocytosis, Langerhans-Cell
2
2024
31
1.080
Why?
RNA-Binding Protein EWS
1
2024
13
0.890
Why?
Neoplasms, Germ Cell and Embryonal
1
2024
22
0.880
Why?
Interleukin-13 Receptor alpha2 Subunit
3
2018
4
0.870
Why?
Central Nervous System Neoplasms
1
2024
61
0.850
Why?
Craniospinal Irradiation
2
2021
9
0.810
Why?
Receptor, erbB-2
4
2025
73
0.790
Why?
Receptors, Antigen, T-Cell
4
2018
49
0.780
Why?
Hypothyroidism
2
2021
56
0.760
Why?
Neoplasm Recurrence, Local
3
2024
622
0.730
Why?
Protons
2
2021
67
0.640
Why?
Antigenic Variation
2
2018
3
0.630
Why?
Receptor, EphA2
1
2018
5
0.590
Why?
Immunotherapy, Adoptive
4
2025
161
0.430
Why?
Cerebellar Neoplasms
3
2022
21
0.430
Why?
Neuroblastoma
2
2024
51
0.410
Why?
Cancer Vaccines
3
2021
80
0.360
Why?
Testicular Hydrocele
1
2010
4
0.350
Why?
Thrombocytopenia
1
2011
82
0.350
Why?
Genital Diseases, Female
1
2010
17
0.350
Why?
Hernia, Inguinal
1
2010
18
0.340
Why?
Vagina
1
2010
43
0.340
Why?
Child
14
2024
6931
0.340
Why?
Humans
26
2025
50419
0.310
Why?
Immunotherapy
4
2024
234
0.310
Why?
Neoplasms
3
2023
1248
0.300
Why?
Antineoplastic Agents
3
2024
1165
0.270
Why?
Child, Preschool
7
2024
3953
0.250
Why?
Neurofibroma, Plexiform
1
2024
4
0.230
Why?
Benzamides
1
2024
50
0.230
Why?
Neurofibromatosis 1
1
2024
31
0.230
Why?
Rhabdoid Tumor
1
2024
11
0.220
Why?
Neoplastic Syndromes, Hereditary
1
2024
15
0.220
Why?
Eyelid Diseases
1
2024
12
0.220
Why?
Xenograft Model Antitumor Assays
3
2020
210
0.210
Why?
Gene Rearrangement
1
2024
63
0.210
Why?
Tumor Cells, Cultured
3
2020
453
0.210
Why?
Glioma
1
2024
74
0.210
Why?
Female
12
2024
27053
0.200
Why?
Bacterial Infections
1
2023
98
0.200
Why?
Bacteremia
1
2023
89
0.200
Why?
Male
10
2024
25866
0.200
Why?
Rhabdomyosarcoma, Alveolar
1
2022
8
0.200
Why?
Sarcoma, Ewing
1
2022
27
0.200
Why?
Proton Therapy
1
2021
11
0.190
Why?
Adrenal Insufficiency
1
2021
18
0.190
Why?
Hematologic Neoplasms
1
2023
99
0.180
Why?
Leukemia
1
2021
65
0.180
Why?
DNA-Binding Proteins
1
2024
410
0.180
Why?
Sepsis
1
2023
225
0.180
Why?
Mice, SCID
2
2018
171
0.170
Why?
Hypothalamic Diseases
1
2020
1
0.170
Why?
Ependymoma
1
2020
7
0.170
Why?
Cerebrospinal Fluid
1
2020
32
0.170
Why?
Methylphenidate
1
2020
76
0.160
Why?
Infant
3
2024
3648
0.160
Why?
Mice
5
2025
5659
0.150
Why?
Mice, Inbred NOD
1
2018
89
0.140
Why?
Weight Loss
1
2020
245
0.140
Why?
Central Nervous System Stimulants
1
2020
209
0.140
Why?
Cell Proliferation
2
2018
980
0.140
Why?
Adolescent
4
2024
6453
0.140
Why?
Receptors, Cell Surface
1
2017
117
0.140
Why?
Diagnosis, Differential
3
2024
1029
0.130
Why?
Tumor Escape
1
2016
17
0.130
Why?
Apoptosis
2
2018
1092
0.120
Why?
Neoplasm Proteins
1
2017
320
0.120
Why?
Animals
5
2025
13063
0.110
Why?
Cell Nucleus
1
2014
183
0.110
Why?
Retrospective Studies
3
2021
6274
0.100
Why?
Up-Regulation
1
2014
446
0.100
Why?
Plasma Cell Granuloma, Pulmonary
1
2011
1
0.090
Why?
Obesity
1
2020
1123
0.090
Why?
Lung Neoplasms
1
2017
597
0.090
Why?
Septo-Optic Dysplasia
1
2011
3
0.090
Why?
Moyamoya Disease
1
2011
7
0.090
Why?
Tumor Microenvironment
2
2024
221
0.090
Why?
Slipped Capital Femoral Epiphyses
1
2011
9
0.090
Why?
Medical History Taking
1
2011
48
0.090
Why?
Lymphocyte Activation
2
2025
169
0.090
Why?
Antigens, Neoplasm
2
2021
148
0.070
Why?
Ultrasonography
1
2010
434
0.070
Why?
Prognosis
3
2020
1974
0.070
Why?
Cell Line, Tumor
2
2025
1393
0.070
Why?
Adult
4
2024
13561
0.060
Why?
Programmed Cell Death 1 Receptor
1
2025
37
0.060
Why?
Young Adult
2
2024
4075
0.060
Why?
MutS Homolog 2 Protein
1
2024
12
0.060
Why?
DNA Mismatch Repair
1
2024
16
0.060
Why?
CTLA-4 Antigen
1
2024
22
0.050
Why?
Follow-Up Studies
2
2020
2231
0.050
Why?
Survival Rate
2
2017
906
0.050
Why?
Fever
1
2023
112
0.050
Why?
Maximum Tolerated Dose
1
2022
39
0.050
Why?
Biopsy
1
2024
588
0.050
Why?
Glucocorticoids
1
2024
233
0.050
Why?
Longitudinal Studies
1
2024
732
0.050
Why?
Growth Hormone
1
2021
97
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2022
224
0.040
Why?
Colorectal Neoplasms
1
2024
256
0.040
Why?
Incidence
1
2024
1027
0.040
Why?
Radiotherapy Dosage
1
2021
248
0.040
Why?
Injections, Intraventricular
1
2020
13
0.040
Why?
HEK293 Cells
1
2020
209
0.040
Why?
Neoplasm Metastasis
1
2020
230
0.040
Why?
Cross-Sectional Studies
1
2024
1601
0.040
Why?
Quality of Life
1
2024
850
0.040
Why?
Drug Delivery Systems
1
2020
143
0.040
Why?
Treatment Outcome
2
2020
5265
0.040
Why?
Mutation
1
2024
1275
0.040
Why?
Anti-Bacterial Agents
1
2023
751
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
997
0.040
Why?
Microfilament Proteins
1
2017
42
0.040
Why?
Aged
2
2024
9738
0.040
Why?
Prospective Studies
1
2023
2378
0.040
Why?
Adenoviridae
1
2017
47
0.030
Why?
Magnetic Resonance Imaging
1
2024
1546
0.030
Why?
Cytomegalovirus
1
2017
28
0.030
Why?
Herpesvirus 4, Human
1
2017
37
0.030
Why?
Interleukin-13
1
2016
14
0.030
Why?
Infant, Newborn
1
2024
2752
0.030
Why?
Neoplasm Transplantation
1
2016
83
0.030
Why?
Transgenes
1
2016
50
0.030
Why?
Middle Aged
2
2024
12579
0.030
Why?
Protein Multimerization
1
2016
50
0.030
Why?
Protein Binding
1
2016
648
0.030
Why?
Case-Control Studies
1
2017
1152
0.030
Why?
Adoptive Transfer
1
2014
29
0.030
Why?
Cell Cycle
1
2014
227
0.030
Why?
Recurrence
1
2014
657
0.020
Why?
Groin
1
2011
16
0.020
Why?
Cough
1
2011
56
0.020
Why?
Hypoglycemia
1
2011
55
0.020
Why?
Penis
1
2011
79
0.020
Why?
Anemia, Sickle Cell
1
2011
95
0.020
Why?
Radiography
1
2011
482
0.020
Why?
Pain
1
2011
386
0.020
Why?
Bielamowicz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description